RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Karl E. Klose to Ligands

Back to Details
This is a "connection" page, showing publications Karl E. Klose has written about Ligands.
Karl E. Klose
Connection Strength
0.078
Ligands
  1. Wang M, Du G, Yongo-Luwawa C, Lu A, Kinrade B, Munro K, Klose KE, Lubell WD, Davies P, Guo S. Peptide-based ligand antagonists block a Vibrio cholerae adhesin. FEBS Lett. 2026 Mar; 600(5):631-643.
    View in: PubMed
    Score: 0.053
  2. Cunningham AL, Dang KM, Yu JJ, Guentzel MN, Heidner HW, Klose KE, Arulanandam BP. Enhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated Francisella tularensis subsp. novicida strain U112?iglB::fljB. Vaccine. 2014 Sep 08; 32(40):5234-40.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support